Octave (formerly ETQ)

ETQ is a provider of enterprise Quality Management System (EQMS), Environmental Health & Safety (EHS), and compliance management software, founded in 1992 with more than 30 years serving quality professionals. The platform has moved from traditional quality management tools to a cloud-native SaaS platform delivering 40+ integrated applications adaptable to individual business environments.

Hexagon AB acquired ETQ on April 1, 2022, for $1.2 billion USD, and ETQ operated within Hexagon's Manufacturing Intelligence division until Hexagon completed the spin-off of Octave Intelligence plc on 22 May 2026. That spin-off combined ETQ, Bricsys, and Hexagon's Asset Lifecycle Intelligence and Safety, Infrastructure & Geospatial divisions into an independent, publicly traded company; ETQ Reliance was rebranded Octave Reliance as part of the transition. Octave Intelligence plc trades as Swedish Depositary Receipts on Nasdaq Stockholm and as ordinary shares on the Nasdaq Global Select Market (ticker OCTV), and is no longer part of Hexagon.

ETQ Reliance, the company's flagship product, serves the Life Sciences Pharmaceutical, Medical Device, Aerospace & Defense, Automotive, Food & Beverage, Chemical & Agroscience, and Manufacturing sectors. The platform emphasizes configurability without custom programming: workflows, forms, sections, fields, and reports can be adapted to specific business requirements while maintaining quality management best practices.

For pharmaceutical and medical device companies, ETQ offers dedicated Life Sciences Compliance applications: 21 CFR Part 11 and EU Annex 11 compliant workflows, electronic signatures, audit trails, Complaints Handling with eMDR (Electronic Medical Device Reporting), Lab Investigations, and validation support. The platform serves 600+ customers globally, including BD (Becton Dickinson), Dexcom, Fresenius Kabi, Philips Healthcare, Terumo, and Zimmer Biomet.

ETQ transformed to a cloud-native SaaS model, with SaaS bookings growing at 60% CAGR from 2019 to 2022 and reaching 50% of total bookings by 2022. At the time of acquisition, ETQ generated $75M in annual revenue with a 35% adjusted operating margin.

ETQ is a generalist enterprise QMS vendor with pharma customers, not a pharma-only specialist. Vendor descriptions list customers across pharmaceuticals, electronics, heavy industry, food and beverage, and medical devices. ETQ states "more than 600 customers globally" across all industries; the pharma-specific subset is undisclosed.

Named pharma customers include Johnson & Johnson, Organon (Merck spin-out, 2021), Cosmo Pharmaceuticals, Huvepharma, Univercells (cell-therapy bioproduction), Revvity, MediSystem, DiscGenics (clinical-stage biotech), and a legacy Novartis citation that has not been refreshed since 2019-2020 marketing. Medical-device customers adjacent to pharma include Illumina, Owen Mumford, Avanos, Symmetry Surgical, Integer, and Cretex Medical. The reference base skews mid-cap pharma, biotech, CDMO/cell-therapy, and generic/consumer-health pharma; named top-10 Big Pharma deployments are limited.

ETQ supports FDA 21 CFR Part 11, EU Annex 11, GMP, ISO 13485, and eMDR / Manufacturer Incident Reporting (MIR). The Life Sciences Compliance application set includes an MIR form, Lab Investigation, and the Reliance Validation Execution Package. DSCSA serialization, FSMA 204 traceability, and PMDA / NMPA / ANVISA / MHRA / Health Canada specific inspection-readiness packages are not prominently claimed. ICH Q7/Q9/Q10 alignment is implied through the GMP/CAPA/risk modules but is not offered as a packaged accelerator.

The customer base fits diversified life-sciences groups spanning med-device, consumer-health, and pharma segments under one platform, in the pattern of J&J and Organon, as well as mid-cap pharma companies with multi-vertical operations. No pharma-specialist systems-integrator ecosystem (Deloitte, IBM, TCS Life Sciences, Cognizant, ProPharma, Halloran) is published on ETQ's partner pages.

Hexagon AB acquired ETQ for $1.2 billion USD on April 1, 2022, on a cash and debt free basis. At acquisition, ETQ generated $75M in annual revenue with a 35% adjusted operating margin.

Before the acquisition, ETQ had raised $25M in total funding, characterized as private equity backing, with TCV named as investor.

From 2019 to 2022, SaaS bookings grew at 60% CAGR, reaching 50% of total bookings by 2022.

Hexagon AB (Publ), publicly traded on Nasdaq Stockholm (HEXA B.ST) with $5+ billion in annual revenue and global operations, owned ETQ from April 2022 until Hexagon completed the spin-off of Octave Intelligence plc on 22 May 2026. ETQ (rebranded Octave Reliance) is now part of the independent, publicly traded Octave Intelligence plc (Nasdaq Stockholm SDRs; Nasdaq Global Select Market: OCTV) rather than Hexagon.

Hexagon's stated rationale for the 2022 acquisition cited a fit across its manufacturing and process industries customer base, scope for geographical expansion, and expected sales synergies of over $40M by 2026 with strong incremental margins. ETQ operated within Hexagon's Manufacturing Intelligence division alongside other quality and operations management solutions until the May 2026 spin-off separated it.

ETQ's customer base is 600+ organizations globally, across pharmaceuticals, medical devices, electronics, heavy industry, food and beverage, manufacturing, and automotive sectors.

ETQ Reliance is the flagship enterprise Quality Management System platform with 40+ configurable applications, grouped into four areas.

Quality Management applications cover Document Control, CAPA Management, Change Control, Non-Conformance Management, Audit Management, Training Management, Supplier Quality Management, Complaint Handling, Deviation Management, Equipment Management, and Quality Events.

Life Sciences Compliance applications cover 21 CFR Part 11 and EU Annex 11 compliant workflows, Electronic Signatures with LDAP authentication, Audit Trails, Complaints Handling with eMDR (Electronic Medical Device Reporting supporting Health Level 7 ICSR standards), Lab Investigations for OOS/OOT events, and a Validation Execution Package with professional validation consulting.

Risk Management applications cover risk assessment and mitigation tracking with configurable workflows. EHS (Environmental, Health & Safety) applications cover safety management and compliance tracking.

The platform is configurable without custom programming: workflows, forms, sections, fields, reports, and the user interface can be adapted to match business requirements while maintaining quality management best practices. It runs on a cloud-native, multi-tenant SaaS architecture, with integration capabilities to SAP, Oracle, and an electronic submission gateway for medical device reporting to regulatory bodies.

Enterprise system integrations with SAP and Oracle. Electronic submission gateway for medical device reporting (eMDR) to FDA and regulatory bodies. LDAP/Active Directory authentication integration. ETQ was part of Hexagon's Manufacturing Intelligence division ecosystem, with potential cross-platform integrations, until the May 2026 spin-off of Octave Intelligence plc separated it from Hexagon.

ETQ provides implementation support, training, and ongoing customer success resources. ETQ was part of Hexagon's Manufacturing Intelligence ecosystem, with access to an extended support network and global service capabilities, until the May 2026 spin-off of Octave Intelligence plc separated it from Hexagon.

Implementation is tiered by organization size and complexity. Small businesses: 2-4 months, $5K-$10K implementation cost. Mid-sized companies (100 users): 4-6 months, $20K-$50K cost. Large enterprises (1000+ users): 6-12 months, $100K-$200K cost. Implementation covers system configuration, workflow design, integration setup, data migration from legacy systems, LDAP/Active Directory integration, user training, and change management.

Validation support for regulated industries follows two approaches: self-validation using the ETQ Reliance Validation Execution Package, which documents platform development, testing, and methodology; or professional validation consulting, with validation consultants supporting compliance with current regulatory requirements and helping organizations understand vendor test records and methodology. Upgrade processes are designed to minimize re-validation effort.

Training and documentation include user training programs, the Octave Community knowledge base, a documentation library, and best-practices guidance. The platform's configurability without programming reduces the need for extensive technical training, shifting the focus to business process and workflow design.

Support quality is reported as inconsistent in customer reviews. Support was delivered as part of Hexagon's global support infrastructure until the May 2026 spin-off separated ETQ into the independent Octave Intelligence plc.

ETQ has operated for 30+ years (founded 1992) and serves 600+ customers globally, including several major life sciences companies. It holds G2 Winter 2025 awards for Usability, Results, and Momentum, and is listed on G2, Capterra, Gartner Peer Insights, GetApp, Software Advice, and TrustRadius.

Hexagon AB acquired ETQ for $1.2 billion in April 2022; Hexagon is publicly traded with $5B+ in revenue. Pre-acquisition, ETQ reported $75M in revenue, a 35% operating margin, and 60% CAGR in SaaS bookings from 2019 to 2022.

Leadership includes CEO Vick Vaishnavi (former SVP/GM at Everbridge), CTO John Taylor (30+ years in IoT/engineering, 12 patents, prior roles at PTC and Axeda), CPO Prashant Darisi (20+ years in product/engineering, prior roles at Everbridge and RSA), CCO Osama Solieman (long-time ETQ employee), CFO Risa Sparks (prior M&A experience at Panorama Education), and CRO Brandon McAllister (prior sales leadership at Everbridge, LinkedIn, and GoGuardian).

A published Avanos Medical case study covers MDSAP compliance achieved across global geographies; a Cooper Tires case study covers IATF 16949 conformance. Named life sciences customers include BD, Dexcom, Fresenius Kabi, Philips Healthcare, Terumo, and Zimmer Biomet.

ETQ claims 21 CFR Part 11 and EU Annex 11 compliance, supported by electronic signatures, audit trails, and validation packages. MDSAP compliance support is documented in customer case studies.

ETQ has operated as an enterprise quality management vendor for 30+ years. Its website carries an active blog, recent press releases (including the G2 Winter 2025 awards), and product documentation.

ETQ is listed on G2 (Winter 2025 awards for Usability, Results, and Momentum), Capterra, Gartner Peer Insights (listed as Octave Reliance), GetApp, Software Advice, and TrustRadius. It serves 600+ customers globally across pharmaceuticals, medical devices, manufacturing, food & beverage, automotive, aerospace & defense, and chemicals.

ETQ publishes blog content and customer case studies. It operates as an enterprise-focused EQMS with particular strength in regulated industries (pharma, medical devices).

ETQ is headquartered in Burlington, MA, with customers across multiple continents. Hexagon AB, its former parent company until the May 2026 spin-off of Octave Intelligence plc, is headquartered in Stockholm, Sweden. Employees are distributed across 6 continents, serving customers internationally.